ArticleProceedings of the National Academy of Sciences of the United States of America2003

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Kozi Ichiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.